DEEF Pharmaceutical Industries started production in June 2007 with the vision of establishing a Saudi factory running by international standards. DEEF founders are results-oriented, aiming for sustainable growth and providing high quality pharmaceutical products in Saudi Arabia and the GCC countries.
Today DEEF has more than 80 registered products, with a rich pipeline underway, covering a vast range of therapeutic areas and special focus on Dermatology, Respiratory, Alimentary tract & Metabolism, Cardiovascular and Central nervous systems.
The plant is located in Al Badaye, Al Qassim 350 Kms North of the Capital Riyadh, on a land area that spans over 90,000 sq. meters, housing related infrastructure and a room for future expansions.
The plant is located in Al Badaye, Al Qassim 360 Kms North of the Capital Riyadh, on a land area that spans over 90,000 sq. meters, housing related infrastructure and a room for future expansions.
DEEF is a closed joint stock company with a capital of SAR 95 million. In 2011, Banaja Holdings acquired 51% of shares. Since then, the company witnessed a major restructuring, expansion of sales force, and attraction of talent in different industry disciplines.
Manufacturing areas are designed and constructed in compliance with highest international standards using MRC (Modular Room Construction).
Manufacturing Lines encompass:
- Oral solid dosage line (Tablets, hard gelatin capsules and sachets).
- Oral liquid line.
- Semisolid line (creams, ointments and gels).
- Antiseptics line.
Manufacturing areas and laboratories are equipped with state-of-the-art machines and testing equipment. Products are manufactured in a safe, effective and high quality manner, in congruence with cGMP as well as other relevant international guidelines.
DEEF spares no efforts to achieve highest quality, not only in our products, but in all our actions and endeavors. Quality is built into our products through its development, sourcing of raw materials, and in every step of production, storage and distribution.
DEEF is currently one of the fastest growing Saudi Pharmaceutical companies offering excellent growth opportunities on both corporate and individual levels.